Compare Kobayashi Pharmaceutical Co., Ltd. with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with a -11.74% CAGR growth in Operating Profits over the last 5 years
2
Poor long term growth as Net Sales has grown by an annual rate of 2.30% and Operating profit at -11.74% over the last 5 years
3
The company has declared negative results for the last 3 consecutive quarters
4
Underperformed the market in the last 1 year
Stock DNA
Pharmaceuticals & Biotechnology
JPY 425,372 Million (Mid Cap)
21.00
NA
0.00%
-0.31
9.53%
2.04
Revenue and Profits:
Net Sales:
37,084 Million
(Quarterly Results - Jun 2026)
Net Profit:
101 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
10.92%
0%
10.92%
6 Months
2.2%
0%
2.2%
1 Year
4.68%
0%
4.68%
2 Years
7.78%
0%
7.78%
3 Years
-16.35%
0%
-16.35%
4 Years
-29.9%
0%
-29.9%
5 Years
-36.58%
0%
-36.58%
Kobayashi Pharmaceutical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
2.30%
EBIT Growth (5y)
-11.74%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.32
Sales to Capital Employed (avg)
0.80
Tax Ratio
17.71%
Dividend Payout Ratio
211.46%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
20.52%
ROE (avg)
10.01%
Valuation key factors
Factor
Value
P/E Ratio
21
Industry P/E
Price to Book Value
2.02
EV to EBIT
25.94
EV to EBITDA
15.80
EV to Capital Employed
2.47
EV to Sales
2.14
PEG Ratio
2.73
Dividend Yield
NA
ROCE (Latest)
9.53%
ROE (Latest)
9.53%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY
Jun'26
Jun'25
Change(%)
Net Sales
37,084.00
36,411.00
1.85%
Operating Profit (PBDIT) excl Other Income
3,319.00
6,239.00
-46.80%
Interest
6.00
8.00
-25.00%
Exceptional Items
-791.00
-2,410.00
67.18%
Consolidate Net Profit
101.00
1,540.00
-93.44%
Operating Profit Margin (Excl OI)
21.90%
113.00%
-9.11%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2026 is 1.85% vs -0.65% in Jun 2025
Consolidated Net Profit
YoY Growth in quarter ended Jun 2026 is -93.44% vs 234.78% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
165,742.00
165,600.00
0.09%
Operating Profit (PBDIT) excl Other Income
23,590.00
32,883.00
-28.26%
Interest
28.00
28.00
Exceptional Items
-18,411.00
-13,687.00
-34.51%
Consolidate Net Profit
3,660.00
10,071.00
-63.66%
Operating Profit Margin (Excl OI)
89.60%
150.10%
-6.05%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 0.09% vs -4.53% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -63.66% vs -50.48% in Dec 2024
About Kobayashi Pharmaceutical Co., Ltd. 
Kobayashi Pharmaceutical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Footer loading






